{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:58:16Z","timestamp":1792180696593,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare but distinct disease that remains poorly understood, especially at proteome level. We report comprehensive mass spectrometry-based proteomic analyses of SPN (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200913) and characterize differences from other pancreatic neoplasms, pancreatic ductal adenocarcinoma (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200911) and neuroendocrine tumor (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200910). We discovered that the SPN proteome is uniquely distinct from that of other pancreatic neoplasms. Lysosome-related proteins are enriched and upstream lysosomal processes transcriptional regulators, MITF and TFE3, are overexpressed in SPN. MITF protein expression is more specific for SPN than TFE3, previously considered the most specific immunohistochemical marker. Since lysosomal-related processes are connected to biological energy generation processes, we profiled metabolic pathways and found that SPN is characterized by higher fatty acid oxidation and lower glycolysis than PDAC and high proteasome pathway activity with many proteasomal proteins upregulated, suggesting a possible link to metabolic adaptation mechanisms in low-nutrient environments. Proteomics characterizes SPN as an immune-cold tumor with low MHC class I expression. Proteome-based receptor tyrosine kinase (RTK) pathway profiling suggests PDGFRA and ERBB2 (HER2) as potential candidates for targeted therapy. Our results provide unique proteomic contribution to the understanding of SPN biology and highlight differences from other pancreatic tumors.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s40364-025-00875-y","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:04:15Z","timestamp":1764227055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deep proteogenomic characterization of pancreatic solid pseudopapillary neoplasm reveals unique features distinct from other pancreatic tumors"],"prefix":"10.1186","volume":"13","author":[{"given":"Atsushi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Klimstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olca","family":"Basturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika M.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H. A.","family":"Roehrl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"3","key":"875_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11894-009-0033-3","volume":"11","author":"SC Huang","year":"2009","unstructured":"Huang SC, Erdman SH. Pediatric juvenile polyposis syndromes: an update. Curr Gastroenterol Rep. 2009;11(3):211\u201319.","journal-title":"Curr Gastroenterol Rep"},{"issue":"6","key":"875_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jamcollsurg.2005.02.011","volume":"200","author":"T Papavramidis","year":"2005","unstructured":"Papavramidis T, Papavramidis S. Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. J Am Coll Surg. 2005;200(6):965\u201372.","journal-title":"J Am Coll Surg"},{"issue":"5","key":"875_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/10408379891244217","volume":"39","author":"JA Buckley","year":"1998","unstructured":"Buckley JA, Vaughn DD, Jabra AA, Askin FB, Fishman EK. CT evaluation of mediastinal masses in children: spectrum of disease with pathologic correlation. Crit Rev Diagn Imag. 1998;39(5):365\u201392.","journal-title":"Crit Rev Diagn Imag"},{"issue":"5","key":"875_CR4","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/hep.510230527","volume":"23","author":"N Ganne-Carri\u00e9","year":"1996","unstructured":"Ganne-Carri\u00e9 N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology (Baltimore, Md). 1996;23(5):1112\u201318.","journal-title":"Hepatol (baltim"},{"issue":"2","key":"875_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/PAS.0000000000000141","volume":"38","author":"JS Estrella","year":"2014","unstructured":"Estrella JS, Li L, Rashid A, Wang H, Katz MH, Fleming JB, et al. Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. Am J Surg Pathol. 2014;38(2):147\u201357.","journal-title":"Am J Surg Pathol"},{"issue":"23","key":"875_CR6","first-page":"8401","volume":"61","author":"Y Tanaka","year":"2001","unstructured":"Tanaka Y, Kato K, Notohara K, Hojo H, Ijiri R, Miyake T, et al. Frequent beta-catenin mutation and cytoplasmic\/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res. 2001;61(23):8401\u201304.","journal-title":"Cancer Res"},{"issue":"4","key":"875_CR7","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0002-9440(10)62563-1","volume":"160","author":"SC Abraham","year":"2002","unstructured":"Abraham SC, Klimstra DS, Wilentz RE, Yeo CJ, Conlon K, Brennan M, et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol. 2002;160(4):1361\u201369.","journal-title":"Am J Pathol"},{"issue":"8","key":"875_CR8","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/1878-0261.12490","volume":"13","author":"P Selenica","year":"2019","unstructured":"Selenica P, Raj N, Kumar R, Brown DN, Arqu\u00e9s O, Reidy D, et al. Solid pseudopapillary neoplasms of the pancreas are dependent on the Wnt pathway. Mol Oncol. 2019;13(8):1684\u201392.","journal-title":"Mol Oncol"},{"key":"875_CR9","doi-asserted-by":"crossref","unstructured":"Aoki M, Hecht A, Kruse U, Kemler R, Vogt PK. Nuclear endpoint of wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. Proc Natl Acad Sci U S A. 1999;96(1):139\u201344.","DOI":"10.1073\/pnas.96.1.139"},{"issue":"12","key":"875_CR10","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1097\/PAS.0b013e318263209d","volume":"36","author":"S La Rosa","year":"2012","unstructured":"La Rosa S, Adsay V, Albarello L, Asioli S, Casnedi S, Franzi F, et al. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers. Am J Surg Pathol. 2012;36(12):1782\u201395.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"875_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/path.1262","volume":"199","author":"Y Tanaka","year":"2003","unstructured":"Tanaka Y, Kato K, Notohara K, Nakatani Y, Miyake T, Ijiri R, et al. Significance of aberrant (cytoplasmic\/nuclear) expression of beta-catenin in pancreatoblastoma. J Pathol. 2003;199(2):185\u201390.","journal-title":"The J Pathol"},{"issue":"1","key":"875_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21(1):144.","journal-title":"Mol Cancer"},{"issue":"4","key":"875_CR13","doi-asserted-by":"publisher","first-page":"e0250619","DOI":"10.1371\/journal.pone.0250619","volume":"16","author":"J An","year":"2021","unstructured":"An J, Woo HY, Lee Y, Kim HS, Jeong J, Kim SK. Clinicopathological features of 70 desmoid-type fibromatoses confirmed by \u03b2-catenin immunohistochemical staining and CTNNB1 mutation analysis. PLoS One. 2021;16(4):e0250619.","journal-title":"PLoS One"},{"issue":"6","key":"875_CR14","doi-asserted-by":"publisher","first-page":"776","DOI":"10.5858\/2005-129-776-IEOCIS","volume":"129","author":"D Rakheja","year":"2005","unstructured":"Rakheja D, Molberg KH, Roberts CA, Jaiswal VR. Immunohistochemical expression of beta-catenin in solitary fibrous tumors. Arch Pathol Lab Med. 2005;129(6):776\u201379.","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"875_CR15","first-page":"782","volume":"3","author":"F Zhang","year":"2010","unstructured":"Zhang F, Tang JM, Wang L, Shen JY, Zheng L, Wu PP, et al. Detection of \u03b2-catenin, gastrokine-2 and embryonic stem cell expressed ras in gastric cancers. Int J Clin Exp Pathol. 2010;3(8):782\u201391.","journal-title":"Int J Clin And Exp Pathol"},{"issue":"2","key":"875_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/path.2524","volume":"218","author":"C Cavard","year":"2009","unstructured":"Cavard C, Audebourg A, Letourneur F, Audard V, Beuvon F, Cagnard N, et al. Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas. J Pathol. 2009;218(2):201\u201309.","journal-title":"The J Pathol"},{"issue":"4","key":"875_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/modpathol.2013.154","volume":"27","author":"M Park","year":"2014","unstructured":"Park M, Kim M, Hwang D, Park M, Kim WK, Kim SK, et al. Characterization of gene expression and activated signaling pathways in solid-pseudopapillary neoplasm of pancreas. Mod Pathol: Off J U States Can Acad Pathol Inc. 2014;27(4):580\u201393.","journal-title":"Mod Pathol: Off J U States Can Acad Pathol, Inc"},{"issue":"8","key":"875_CR18","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1021\/acs.jproteome.5b00423","volume":"14","author":"M Park","year":"2015","unstructured":"Park M, Lim JS, Lee HJ, Na K, Lee MJ, Kang CM, et al. Distinct protein expression profiles of solid-pseudopapillary neoplasms of the pancreas. J Proteome Res. 2015;14(8):3007\u201314.","journal-title":"J Proteome Res"},{"issue":"10","key":"875_CR19","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1074\/mcp.M114.038786","volume":"13","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Xu H, Chen H, Xie J, Shi M, Shen B, et al. Proteomic analysis of solid pseudopapillary tumor of the pancreas reveals dysfunction of the endoplasmic reticulum protein processing pathway. Mol Cell Proteomics. 2014;13(10):2593\u2013603.","journal-title":"Mol Cell Proteomics"},{"issue":"11","key":"875_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651\u201368.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"875_CR21","doi-asserted-by":"publisher","first-page":"110544","DOI":"10.1016\/j.isci.2024.110544","volume":"27","author":"A Tanaka","year":"2024","unstructured":"Tanaka A, Ogawa M, Zhou Y, Otani Y, Hendrickson RC, Miele MM, et al. Proteogenomic characterization of pancreatic neuroendocrine tumors uncovers hypoxia and immune signatures in clinically aggressive subtypes. iScience. 2024;27(8):110544.","journal-title":"iScience"},{"issue":"3","key":"875_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"Cheng DT, Mitchell TN, Zehir A, Shah RH, Benayed R, Syed A, et al. Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn. 2015;17(3):251\u201364.","journal-title":"J Mol Diagn"},{"issue":"2","key":"875_CR23","doi-asserted-by":"publisher","first-page":"113810","DOI":"10.1016\/j.celrep.2024.113810","volume":"43","author":"A Tanaka","year":"2024","unstructured":"Tanaka A, Ogawa M, Zhou Y, Namba K, Hendrickson RC, Miele MM, et al. Proteogenomic characterization of primary colorectal cancer and metastatic progression identifies proteome-based subtypes and signatures. Cell Rep. 2024;43(2):113810.","journal-title":"Cell Rep"},{"issue":"1","key":"875_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41698-024-00708-5","volume":"8","author":"A Tanaka","year":"2024","unstructured":"Tanaka A, Ogawa M, Zhou Y, Hendrickson RC, Miele MM, Li Z, et al. Proteomic basis for pancreatic acinar cell carcinoma and pancreatoblastoma as similar yet distinct entities. NPJ Precis Oncol. 2024;8(1):221.","journal-title":"Npj Precis Oncol"},{"issue":"6","key":"875_CR25","first-page":"520","volume":"17","author":"O Troyanskaya","year":"2001","unstructured":"Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, et al. Missing value estimation methods for DNA microarrays. Bioinformatics (Oxford, England). 2001;17(6):520\u201325.","journal-title":"Bioinf (oxford, Engl)"},{"issue":"1","key":"875_CR26","first-page":"139","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (Oxford, England). 2010;26(1):139\u201340.","journal-title":"Bioinf (oxford, Engl)"},{"issue":"1","key":"875_CR27","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"7269","key":"875_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462(7269):108\u201312.","journal-title":"Nature"},{"issue":"1","key":"875_CR29","doi-asserted-by":"publisher","first-page":"22085","DOI":"10.1038\/s41598-020-79049-9","volume":"10","author":"A Tanaka","year":"2020","unstructured":"Tanaka A, Wang JY, Shia J, Zhou Y, Ogawa M, Hendrickson RC, et al. DEAD-box RNA helicase protein DDX21 as a prognosis marker for early stage colorectal cancer with microsatellite instability. Sci Rep. 2020;10(1):22085.","journal-title":"Sci Rep"},{"key":"875_CR30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3389\/fonc.2020.00945","volume":"10","author":"A Tanaka","year":"2020","unstructured":"Tanaka A, Wang JY, Shia J, Zhou Y, Ogawa M, Hendrickson RC, et al. Maspin as a prognostic marker for early stage colorectal cancer with microsatellite instability. Front Oncol. 2020;10:945.","journal-title":"Front Oncol"},{"issue":"4","key":"875_CR31","doi-asserted-by":"publisher","first-page":"e0229252","DOI":"10.1371\/journal.pone.0229252","volume":"15","author":"A Tanaka","year":"2020","unstructured":"Tanaka A, Zhou Y, Ogawa M, Shia J, Klimstra DS, Wang JY, Roehrl MH. STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability. PLoS One. 2020;15(4):e0229252.","journal-title":"PLoS One"},{"issue":"8","key":"875_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.18632\/oncotarget.27491","volume":"11","author":"A Tanaka","year":"2020","unstructured":"Tanaka A, Zhou Y, Shia J, Ginty F, Ogawa M, Klimstra DS, et al. Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer. Oncotarget. 2020;11(8):813\u201324.","journal-title":"Oncotarget"},{"key":"875_CR33","doi-asserted-by":"publisher","first-page":"802548","DOI":"10.3389\/fonc.2022.802548","volume":"12","author":"M Ogawa","year":"2022","unstructured":"Ogawa M, Tanaka A, Namba K, Shia J, Wang JY, Roehrl MH. Early-stage loss of GALNT6 predicts poor clinical outcome in colorectal cancer. Front Oncol. 2022;12:802548.","journal-title":"Front Oncol"},{"issue":"1","key":"875_CR34","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1038\/s41598-022-06772-w","volume":"12","author":"M Ogawa","year":"2022","unstructured":"Ogawa M, Tanaka A, Namba K, Shia J, Wang JY, Roehrl MHA. Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer. Sci Rep. 2022;12(1):2767.","journal-title":"Sci Rep"},{"issue":"5","key":"875_CR35","doi-asserted-by":"publisher","first-page":"e0298362","DOI":"10.1371\/journal.pone.0298362","volume":"19","author":"M Ogawa","year":"2024","unstructured":"Ogawa M, Tanaka A, Maekawa M, Namba K, Otani Y, Shia J, et al. Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancer. PLoS One. 2024;19(5):e0298362.","journal-title":"PLoS One"},{"key":"875_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, M\u00fcller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinf. 2011;12:77.","journal-title":"BMC Bioinf"},{"key":"875_CR37","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"1","key":"875_CR38","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41467-024-45306-y","volume":"15","author":"S Tang","year":"2024","unstructured":"Tang S, Wang Y, Luo R, Fang R, Liu Y, Xiang H, et al. Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma. Nat Commun. 2024;15(1):1381.","journal-title":"Nat Commun"},{"issue":"1","key":"875_CR39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"key":"875_CR40","unstructured":"Team RC. R: a language and environment for statistical computing. 2021."},{"key":"875_CR41","doi-asserted-by":"publisher","first-page":"771587","DOI":"10.3389\/fsurg.2021.771587","volume":"8","author":"X Wang","year":"2021","unstructured":"Wang X, Zhu D, Bao W, Li M, Wang S, Shen R. Prognostic enigma of pancreatic solid pseudopapillary neoplasm: a single-center experience of 63 patients. Front Surg. 2021;8:771587.","journal-title":"Front Surg"},{"issue":"7643","key":"875_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543(7643):65\u201371.","journal-title":"Nature"},{"issue":"2","key":"875_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","volume":"32","author":"Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma","year":"2017","unstructured":"Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017;32(2):185\u2013203.e13.","journal-title":"Cancer Cell"},{"issue":"2","key":"875_CR44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.path.2011.03.001","volume":"4","author":"N Ohike","year":"2011","unstructured":"Ohike N, Morohoshi T. Exocrine pancreatic neoplasms of nonductal origin: acinar cell carcinoma, Pancreatoblastoma, and solid-pseudopapillary neoplasm. Surg Pathol Clin. 2011;4(2):579\u201388.","journal-title":"Surg Pathol Clin"},{"issue":"3","key":"875_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000515446","volume":"65","author":"T Farzaneh","year":"2021","unstructured":"Farzaneh T, Nowroozizadeh B, Han M, Lee W. Diagnostic utility of LEF1 immunostain in cytology specimens of solid pseudopapillary neoplasm of pancreas. Acta Cytol. 2021;65(3):250\u201356.","journal-title":"Acta Cytol"},{"issue":"2","key":"875_CR46","first-page":"1390","volume":"16","author":"Y Tang","year":"2018","unstructured":"Tang Y, Zhou J, Hooi SC, Jiang YM, Lu GD. Fatty acid activation in carcinogenesis and cancer development: essential roles of long-chain acyl-CoA synthetases. Oncol Lett. 2018;16(2):1390\u201396.","journal-title":"Oncol Lett"},{"key":"875_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinf. 2003;4:2.","journal-title":"BMC Bioinf"},{"issue":"5939","key":"875_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.1174447","volume":"325","author":"M Sardiello","year":"2009","unstructured":"Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, et al. A gene network regulating lysosomal biogenesis and function. Science (New York, NY). 2009;325(5939):473\u201377.","journal-title":"Sci (new Y, NY)"},{"issue":"11","key":"875_CR49","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.4161\/auto.7.11.17166","volume":"7","author":"C Settembre","year":"2011","unstructured":"Settembre C, Ballabio A. TFEB regulates autophagy: an integrated coordination of cellular degradation and recycling processes. Autophagy. 2011;7(11):1379\u201381.","journal-title":"Autophagy"},{"issue":"309","key":"875_CR50","doi-asserted-by":"publisher","first-page":"ra9","DOI":"10.1126\/scisignal.2004754","volume":"7","author":"JA Martina","year":"2014","unstructured":"Martina JA, Diab HI, Lishu L, Jeong AL, Patange S, Raben N, Puertollano R. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci Signal. 2014;7(309):ra9.","journal-title":"Sci Signal"},{"issue":"5","key":"875_CR51","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"6467","key":"875_CR52","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","volume":"366","author":"C Pohl","year":"2019","unstructured":"Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science (New York, NY). 2019;366(6467):818\u201322.","journal-title":"Sci (new Y, NY)"},{"issue":"2","key":"875_CR53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrc3205","volume":"12","author":"E Gherardi","year":"2012","unstructured":"Gherardi E, Birchmeier W, Birchmeier C, Vande Woude G. Targeting met in cancer: rationale and progress. Nat Rev Cancer. 2012;12(2):89\u2013103.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"875_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13045-024-01558-1","volume":"17","author":"P Zhang","year":"2024","unstructured":"Zhang P, Yue L, Leng Q, Chang C, Gan C, Ye T, Cao D. Targeting FGFR for cancer therapy. J Hematol Oncol. 2024;17(1):39.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"875_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40364-024-00565-1","volume":"12","author":"K Zhu","year":"2024","unstructured":"Zhu K, Yang X, Tai H, Zhong X, Luo T, Zheng H. HER2-targeted therapies in cancer: a systematic review. Biomark Res. 2024;12(1):16.","journal-title":"Biomark Res"},{"issue":"4","key":"875_CR56","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ccell.2025.02.018","volume":"43","author":"L Mayr","year":"2025","unstructured":"Mayr L, Neyazi S, Schwark K, Trissal M, Beck A, Labelle J, et al. Effective targeting of PDGFRA-altered high-grade glioma with avapritinib. Cancer Cell. 2025;43(4):740\u201356 e8.","journal-title":"Cancer Cell"},{"issue":"4","key":"875_CR57","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2019.10.007","volume":"179","author":"DJ Clark","year":"2019","unstructured":"Clark DJ, Dhanasekaran SM, Petralia F, Pan J, Song X, Hu Y, et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell. 2019;179(4):964\u201383 e31.","journal-title":"Cell"},{"key":"875_CR58","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.humpath.2018.07.005","volume":"81","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Xie J, Wang B, Mu Y, Liu P. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas. Hum Pathol. 2018;81:166\u201375.","journal-title":"Hum Pathol"},{"key":"875_CR59","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12967-015-0718-3","volume":"13","author":"P Li","year":"2015","unstructured":"Li P, Hu Y, Yi J, Li J, Yang J, Wang J. Identification of potential biomarkers to differentially diagnose solid pseudopapillary tumors and pancreatic malignancies via a gene regulatory network. J Transl Med. 2015;13:361.","journal-title":"J Transl Med"},{"issue":"9","key":"875_CR60","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrc4005","volume":"15","author":"A Gk","year":"2015","unstructured":"Alderton GK. Autophagy: surviving stress in pancreatic cancer. Nat Rev Cancer. 2015;15(9):513.","journal-title":"Nat Rev Cancer"},{"issue":"7565","key":"875_CR61","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature14587","volume":"524","author":"RM Perera","year":"2015","unstructured":"Perera RM, Stoykova S, Nicolay BN, Ross KN, Fitamant J, Boukhali M, et al. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature. 2015;524(7565):361\u201365.","journal-title":"Nature"},{"issue":"6","key":"875_CR62","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ncb2718","volume":"15","author":"C Settembre","year":"2013","unstructured":"Settembre C, De Cegli R, Mansueto G, Saha PK, Vetrini F, Visvikis O, et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat Cell Biol. 2013;15(6):647\u201358.","journal-title":"Nat Cell Biol"},{"key":"875_CR63","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3389\/fonc.2020.01401","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu Y, White KA, Barber DL. Intracellular pH regulates cancer and stem cell behaviors: a protein dynamics perspective. Front Oncol. 2020;10:1401.","journal-title":"Front Oncol"},{"issue":"1","key":"875_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12943-024-02205-6","volume":"24","author":"K Huang","year":"2025","unstructured":"Huang K, Han Y, Chen Y, Shen H, Zeng S, Cai C. Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy. Mol Cancer. 2025;24(1):7.","journal-title":"Mol Cancer"},{"issue":"1","key":"875_CR65","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang CH, Li N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer. 2024;23(1):203.","journal-title":"Mol Cancer"},{"issue":"7","key":"875_CR66","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41419-018-0806-4","volume":"9","author":"P Tsvetkov","year":"2018","unstructured":"Tsvetkov P, Adler J, Myers N, Biran A, Reuven N, Shaul Y. Oncogenic addiction to high 26S proteasome level. Cell Death Dis. 2018;9(7):773.","journal-title":"Cell Death Dis"},{"issue":"7","key":"875_CR67","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","volume":"14","author":"EE Manasanch","year":"2017","unstructured":"Manasanch EE, Orlowski RZ. Proteasome inhibitors in cancer therapy. Nat Rev Clin Oncol. 2017;14(7):417\u201333.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"875_CR68","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12964-021-00789-w","volume":"19","author":"HB Li","year":"2021","unstructured":"Li HB, Yang ZH, Guo QQ. Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review. Cell Commun Signal. 2021;19(1):117.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"875_CR69","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-019-1117-9","volume":"18","author":"X Liu","year":"2019","unstructured":"Liu X, Xu J, Zhang B, Liu J, Liang C, Meng Q, et al. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications. Mol Cancer. 2019;18(1):184.","journal-title":"Mol Cancer"},{"key":"875_CR70","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol. 2014;5:614.","journal-title":"Front Immunol"},{"issue":"85","key":"875_CR71","doi-asserted-by":"publisher","first-page":"eadd4817","DOI":"10.1126\/sciimmunol.add4817","volume":"8","author":"O Zimmermannova","year":"2023","unstructured":"Zimmermannova O, Ferreira AG, Ascic E, Velasco Santiago M, Kurochkin I, Hansen M, et al. Restoring tumor immunogenicity with dendritic cell reprogramming. Sci Immunol. 2023;8(85):eadd4817.","journal-title":"Sci Immunol"},{"key":"875_CR72","doi-asserted-by":"crossref","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garc\u00eda-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The pride database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543\u2013d52.","DOI":"10.1093\/nar\/gkab1038"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00875-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-025-00875-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00875-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T06:05:50Z","timestamp":1767074750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-025-00875-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["875"],"URL":"https:\/\/doi.org\/10.1186\/s40364-025-00875-y","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MSKCC and BIDMC Institutional Review Boards (16\u20131683, 2023P000933) approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}